Matrix Capital Management Company, LP - Q3 2019 holdings

$4.05 Billion is the total value of Matrix Capital Management Company, LP's 24 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 33.3% .

 Value Shares↓ Weighting
CRM BuySALESFORCE COM INC$745,017,000
+513.8%
5,018,975
+527.4%
18.38%
+719.1%
ADPT  ADAPTIVE BIOTECHNOLOGIES COR$535,565,000
-36.0%
17,332,1910.0%13.21%
-14.6%
NFLX  NETFLIX INC$535,240,000
-27.1%
2,000,0000.0%13.20%
-2.7%
TDG  TRANSDIGM GROUP INC$321,661,000
+7.6%
617,7830.0%7.94%
+43.7%
MU BuyMICRON TECHNOLOGY INC$266,532,000
+32.8%
6,220,128
+19.6%
6.58%
+77.3%
AMAT  APPLIED MATLS INC$212,075,000
+11.1%
4,250,0000.0%5.23%
+48.3%
FB  FACEBOOK INCcl a$186,699,000
-7.7%
1,048,4000.0%4.61%
+23.2%
AMZN  AMAZON COM INC$180,708,000
-8.3%
104,1000.0%4.46%
+22.3%
QCOM BuyQUALCOMM INC$167,816,000
+10.3%
2,200,000
+10.0%
4.14%
+47.2%
CARG  CARGURUS INC$166,853,000
-14.3%
5,391,0480.0%4.12%
+14.4%
INCY SellINCYTE CORP$143,587,000
-57.9%
1,934,347
-51.8%
3.54%
-43.8%
SGEN SellSEATTLE GENETICS INC$136,499,000
-37.2%
1,598,352
-49.1%
3.37%
-16.2%
DOCU  DOCUSIGN INC$107,813,000
+24.6%
1,741,1660.0%2.66%
+66.2%
WDAY SellWORKDAY INCcl a$101,976,000
-64.6%
600,000
-57.1%
2.52%
-52.7%
Z  ZILLOW GROUP INCcl c cap stk$72,761,000
-35.7%
2,440,0000.0%1.80%
-14.2%
ADAP  ADAPTIMMUNE THERAPEUTICS PLCsponds adr$42,280,000
-62.4%
28,000,0000.0%1.04%
-49.9%
PTC NewPTC INC$39,722,000582,600
+100.0%
0.98%
XLNX NewXILINX INC$28,770,000300,000
+100.0%
0.71%
ALTR NewALTAIR ENGR INC$24,394,000704,625
+100.0%
0.60%
DVA SellDAVITA INC$23,513,000
-78.5%
412,000
-78.8%
0.58%
-71.2%
NEWR BuyNEW RELIC INC$6,791,000
+800.7%
110,514
+1168.2%
0.17%
+1100.0%
SQ SellSQUARE INCcl a$5,929,000
-96.1%
95,700
-95.4%
0.15%
-94.8%
 TRILLIUM THERAPEUTICS INC$704,000
-6.5%
2,288,5600.0%0.02%
+21.4%
UPLD NewUPLAND SOFTWARE INC$349,00010,000
+100.0%
0.01%
ESTC ExitELASTIC N V$0-750,000
-100.0%
-1.04%
ATVI ExitACTIVISION BLIZZARD INC$0-1,200,000
-100.0%
-1.05%
STZ ExitCONSTELLATION BRANDS INCcl a$0-565,500
-100.0%
-2.06%
DATA ExitTABLEAU SOFTWARE INCcl a$0-3,825,000
-100.0%
-11.74%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
TRANSDIGM GROUP INC42Q3 202313.3%
WORKDAY INC42Q3 202319.7%
NETFLIX INC37Q2 202226.1%
NEW RELIC INC29Q1 20227.8%
DAVITA INC26Q3 20196.1%
ADAPTIMMUNE THERAPEUTICS PLC26Q3 20236.8%
SALESFORCE INC23Q3 202218.4%
CONSTELLATION BRANDS INC23Q2 20195.7%
AMAZON COM INC21Q3 202311.2%
TABLEAU SOFTWARE INC20Q2 201915.2%

View Matrix Capital Management Company, LP's complete holdings history.

Latest significant ownerships (13-D/G)
Matrix Capital Management Company, LP Q3 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Adaptimmune Therapeutics PLCJuly 10, 2023233,845,11017.3%
Zentalis Pharmaceuticals, Inc.June 20, 202313,959,97319.8%
ForgeRock, Inc.Sold outFebruary 13, 202300.0%
NEW RELIC, INC.Sold outFebruary 13, 202300.0%
Perimeter Solutions, SAFebruary 13, 20238,587,5005.4%
Aura Biosciences, Inc.December 07, 20225,362,87014.5%
Adaptive Biotechnologies CorpFebruary 14, 202211,572,5908.2%
BigCommerce Holdings, Inc.Sold outFebruary 14, 202200.0%
CarGurus, Inc.Sold outFebruary 16, 202100.0%
Trillium Therapeutics Inc.Sold outFebruary 14, 202000.0%

View Matrix Capital Management Company, LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-13
SC 13G/A2024-02-13
13F-HR2023-11-14
42023-11-09
SC 13D/A2023-11-09
13F-HR2023-08-14
SC 13G/A2023-07-10
42023-06-20
SC 13D/A2023-06-20
13F-HR2023-05-15

View Matrix Capital Management Company, LP's complete filings history.

Compare quarters

Export Matrix Capital Management Company, LP's holdings